Frontotemporal dementia: Assessment, management and considerations for culturally diverse and low resource settings

apa-logo_white_screenThe International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content.
Educational Objectives
  1. Explain how to distinguish behavioural-variant frontotemporal dementia from other dementia and psychiatric syndromes
  2. Discuss how bilingualism can influence the clinical presentation of primary progressive aphasia
  3. Describe how to approach a diagnostic assessment for the most common frontotemporal dementia subtypes


Course Information
Target Audience:Intermediate
Availability:Date Available: 2021-09-10
  You may obtain CE for this webinar at any time.
Offered for CE Yes
Cost Members $20
  Non-Members $30
Refund Policy This webinar is not eligible for refunds
CE Credits 1.0
Frontotemporal dementia is a relatively rare dementia syndrome characterised by insidious and progressive changes in behaviour and personality. Currently, no disease-modifying treatment or cure exists, and differential diagnosis is challenging. In this webinar we will provide an overview of current clinical recommendations for the diagnosis of behavioural-variant frontotemporal dementia, with a focus on differentiation from Alzheimer’s disease and from primary psychiatric disorders. We will also outline assessment approaches for the diagnosis of primary progressive aphasias. We will discuss recent studies examining cross-linguistic studies in primary progressive aphasia and how bilingualism can influence the clinical phenotype. How to approach diagnosis in a low resource setting will be considered. Finally, we will provide an overview of available management and treatment options.

  1. Ducharme, Dols, Laforce, Devenney, Kumfor, van den Stock, . . . Vijverberg. (2020). Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain.
  2. Harvey, Skelton-Robinson, & Rossor. (2003). The prevalence and causes of dementia in people under the age of 65 years. Journal of Neurology, Neurosurgery and Psychiatry, 74(9), 1206-1209.
  3. Hornberger, Piguet, Graham, Nestor, & Hodges. (2010). How preserved is episodic memory in behavioural variant frontotemporal dementia. Neurology, 74(6), 473-479.
  4. Hutchings, Hodges, Piguet, & Kumfor. (2015). Why Should I Care? Dimensions of Socio-Emotional Cognition in Younger-Onset Dementia. Journal of Alzheimer's Disease, 48(1), 135-147.
  5. Kamminga, Kumfor, Burrell, Piguet, Hodges, & Irish. (2015). Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: An examination of clinical characteristics and emotion processing. Journal of Neurology, Neurosurgery and Psychiatry, 86, 1082-1088.
  6. ​​​​​​​Kumfor, Honan, McDonald, Hazelton, Hodges, & Piguet. (2017). Assessing the “social brain” in dementia: Applying TASIT-S. Cortex, 93, 166-177.
  7. Kumfor, Irish, Hodges, & Piguet. (2013). The orbitofrontal cortex is involved in emotional enhancement of memory: Evidence from the dementias. Brain, 136, 2992-3003.
  8. Kumfor, Irish, Leyton, Miller, Lah, Devenney, . . . Piguet. (2014). Tracking the progression of social cognition in neurodegenerative disorders. Journal of Neurology, Neurosurgery and Psychiatry, 85(10), 1076-1083.
  9. Kumfor, Landin-Romero, Devenney, Hutchings, Grasso, Hodges, & Piguet. (2016). On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. Brain, 139(Pt 3), 986-998.
  10. Landin-Romero, Tan, Hodges, & Kumfor. (2016). An update on semantic dementia: genetics, imaging, and pathology. Alzheimer's Research & Therapy, 8(1), 52.
  11. McDonald, Allen, Honan, Padgett, Kumfor, Piguet, & Hazelton. (2017). TASIT-S: an abbreviated version of The Awareness of Social Inference Test. New normative data for Australian and US speakers. Paper presented at the 40th Annual Australian Society for the Study of Brain Impairment (ASSBI) Brain Impairment Conference.
  12. ​​​​​​​Meeter, Kaat, Rohrer, & Van Swieten. (2017). Imaging and fluid biomarkers in frontotemporal dementia. Nature Reviews Neurology, 13(7), 406-419.
  13. Ranasinghe, Rankin, Lobach, Kramer, Sturm, Bettcher, . . . Miller. (2016). Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology, 86(7), 600.
  14. Rascovsky, Hodges, Knopman, Mendez, Kramer, Neuhaus, . . . Miller. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(9), 2456-2477.
  15. Shinagawa, Catindig, Block, Miller, & Rankin. (2016). When a little knowledge can be dangerous: false-positive diagnosis of behavioral variant frontotemporal dementia among community clinicians. Dementia and Geriatric Cognitive Disorders, 41(1-2), 99-108.
  16. Thijssen, La Joie, Wolf, Strom, Wang, Iaccarino, . . . Spina. (2020). Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration. Nature Medicine, 26(3), 387-397.
  17. Ulugut Erkoyun, Groot, Heilbron, Nelissen, van Rossum, Jutten, . . . Pijnenburg. (2020). A clinical-radiological framework of the right temporal variant of frontotemporal dementia. Brain, 143(9), 2831-2843.
  18. van der Flier, & Scheltens. (2005). Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery and Psychiatry, 76(suppl 5), v2-v7.
  19. Vivanti, Tao, Lyall, Robins, & Shea. (2021). The prevalence and incidence of early‐onset dementia among adults with autism spectrum disorder. Autism Research.
  20. Woolley, Khan, Murthy, Miller, & Rankin. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. The Journal of clinical psychiatry, 72(2), 126-133.
  21. Alladi S, Bak TH, Shailaja M, Gollahalli D, Rajan A, Surampudi B, Hornberger M, Duggirala V, Chaudhuri JR, Kaul S. Bilingualism delays the onset of behavioral but not aphasic forms of frontotemporal dementia. Neuropsychologia. 2017 May;99:207-212. doi: 10.1016/j.neuropsychologia.2017.03.021. Epub 2017 Mar 18. PMID: 28322905.
  22. Alladi S, Bak TH, Duggirala V, Surampudi B, Shailaja M, Shukla AK, Chaudhuri JR, Kaul S. Bilingualism delays age at onset of dementia, independent of education and immigration status. Neurology. 2013 Nov 26;81(22):1938-44. doi: 10.1212/01.wnl.0000436620.33155.a4. Epub 2013 Nov 6. PMID: 24198291.
  23. Auclair-Ouellet, N., Fossard, M., Houde, M., Laforce, R., & Macoir, J. (2016). Production of morphologically derived words in the semantic variant of primary progressive aphasia: Preserved decomposition and composition but impaired validation. Neurocase, 22, 170–178. http://dx
  24. ​​​​​​​Bialystok E, Craik FI, Freedman M. Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia. 2007 Jan 28;45(2):459-64. doi: 10.1016/j.neuropsychologia.2006.10.009. Epub 2006 Nov 27. PMID: 17125807.
  25. Billette OV, Preiß D, Nestor PJ. The concept of regularization: Resolving the problem of surface dyslexia in semantic variant primary progressive aphasia across different languages. Neuropsychology. 2020 Mar;34(3):298-307. doi: 10.1037/neu0000611. Epub 2019 Dec 23. PMID: 31868373.
  26. Boon Lead Tee, Jessica Deleon, Lorinda Kwan Chen Li Ying, Bruce L. Miller, Raymond Y. Lo, Eduardo Europa, Swati Sudarsan, Stephanie Grasso & Maria Luisa Gorno-Tempini (2021) Tonal and orthographic analysis in a Cantonese-speaking individual with nonfluent/agrammatic variant primary progressive aphasia, Neurocase, DOI: 10.1080/13554794.2021.1925302
  27. Boxer AL, Knopman DS, Kaufer DI, et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013;12(2):149–56.
  28. Boxer, AL, Gold, M, Feldman, H, et al. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. Alzheimer'sDement. 2020; 16: 131– 143.
  29. Canu, E., Agosta, F., Battistella, G., Spinelli, E. G., DeLeon, J., Welch, A. E., Mandelli, M. L., Hubbard, H. I., Moro, A., Magnani, G., Cappa, S. F., Miller, B. L., Filippi, M., & Gorno-Tempini, M. L. (2020). Speech production differences in English and Italian speakers with nonfluent variant PPA. Neurology, 94(10), e1062–e1072.
  30. ​​​​​​​Clare L, Whitaker CJ, Craik FI, Bialystok E, Martyr A, Martin-Forbes PA, Bastable AJM, Pye KL, Quinn C, Thomas EM, Gathercole VC, Hindle JV (2014) . Bilingualism, executive control, and age at diagnosis among people 465 with early-stage Alzheimer’s disease in Wales. J Neuropsy466 chol 10, 163-185.
  31. Costa AS, Jokel R, Villarejo A, Llamas-Velasco S, Domoto-Reil- ley K, Wojtala J, Reetz K, Machado Á (2019) Bilingualism in primary progressive aphasia: a retrospective study on clinical and language characteristics. Alzheimer Dis Assoc Disord 33:47–53.
  32. Craik FI, Bialystok E, Freedman M (2010) Delaying the 393 onset of Alzheimer disease: Bilingualism as a form of cognitive reserve. Neurology 75, 1726-1729.
  33. de Leon J, Grasso SM, Welch A, Miller Z, Shwe W, Rabinovici GD, Miller BL, Henry ML, Gorno-Tempini ML. Effects of bilingualism on age at onset in two clinical Alzheimer's disease variants. Alzheimers Dement. 2020 Dec;16(12):1704-1713. doi: 10.1002/alz.12170. Epub 2020 Sep 3. PMID: 32881346; PMCID: PMC7902304.
  34. Devanand DP, Pelton GH, D’Antonio K, et al. Low-dose lithium treatment for agitation and psychosis in Alzheimer disease and frontotemporal dementia: a case series. Alzheimer Dis Assoc Diord. 2017;31(1):73–5
  35. Ellajosyula R, Narayanan J, Patterson K. Striking loss of second language in bilingual patients with semantic dementia. J Neurol. 2020 Feb;267(2):551-560. doi: 10.1007/s00415-019-09616-2. Epub 2019 Nov 8. PMID: 31705289.
  36. ​​​​​​​Filley, C.M., Ramsberger, G., Menn, L. et al. (2006). Primary progressive aphasia in a bilingual woman. Neurocase 12 (5): 296–299. doi:10.1080/13554790601126047
  37. Finger EC, MacKinley J, Blair M, et al. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability. Neurology. 2015;84(2):174–81
  38. Fushimi, T., Komori, K., Ikeda, M., Lambon Ralph, M. A., & Patterson, K. (2009). The association between semantic dementia and surface dyslexia in Japanese. Neuropsychologia, 47, 1061–1068. .1016/j.neuropsychologia.2008.12.030
  39. Ghosh A, Dutt A, Ghosh M et al (2013) Using the revised diagnostic criteria for Frontotemporal dementia in India: evidence of an advanced and florid disease. PLoS One 8:e60999
  40. Ghosh A, Dutt A (2010) Utilisation behaviour in frontotemporal dementia. J Neurol Neurosurg Psychiatry 81:154–156
  41. Gollan TH, Salmon DP, Montoya RI, Galasko DR (2011). Degree of bilingualism predicts age of diagnosis of 447 Alzheimer’s disease in low-education but not in highly educated Hispanics. Neuropsychologia 49, 3826-3830.
  42. Grasso, S.M., E.D. Peña, N. Kazemi, H. Mirzapour, R. Neupane, B. Bonakdarpour, M.L. Gorno-Tempini, and M.L. Henry. 'Treatment for Anomia in Bilingual Speakers with Progressive Aphasia.', Submitted.
  43. Grosjean F.
  44. Hernandez M, Cano A, Costa A, Sebastian-Galles N, Juncadella M, Gascon-Bayarri J (2008) Grammatical category-specific deficits in bilingual aphasia. Brain Lang 107:68–80. https://doi. org/10.1016/j.bandl.2008.01.006
  45. Huey ED, Garcia C, Wassermann EM, et al. Stimulant treatment of frontotemporal dementia in 8 patients. J Clin Psychiatry. 2008;69(12):1981–2.
  46. Herrmann N, Black SE, Chow T, et al. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry. 2012;20(9):789–97.
  47. Ikeda M, Shigenobu K, Fukuhara R, et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotempo- ral lobar degeneration patients. Demen Geriatr Cogn Disord. 2004;17(3):117–21.
  48. ​​​​​​​Jesso S, Morlog D, Ross S, et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain. 2011;134(Pt 9):2493–501.
  49. Josephs K, Hu W, Hillis A et al (2016) Frontotemporal dementia in patients of African descent. J Neurochem 138:229
  50. Kambanaros M, Grohmann KK (2011) BATting multilingual primary progressive aphasia for Greek, English, and Czech. J Neurolinguist 25:520–537. .2011.01.006
  51. Kavé, G., Heinik, J., & Biran, I. (2012). Preserved morphological process- ing in semantic dementia. Cognitive Neuropsychology, 29, 550–568.
  52. Kertesz A, Morlog D, Light M, et al. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008;25(2):178–85.
  53. Khoury R, Liu Y, Sheheryar Q, Grossberg GT. Pharmacotherapy for Frontotemporal Dementia. CNS Drugs. 2021 Apr;35(4):425-438. doi: 10.1007/s40263-021-00813-0. Epub 2021 Apr 11. PMID: 33840052.
  54. ​​​​​​​Larner AJ (2012) Progressive non-fluent aphasia in a bilingual subject: Relative preservation of “Mother Tongue”. J Neuropsychiatry Clin Neurosci 24:E9–E10. neuropsych.11010019
  55. Liu M-N, Lau C-I, Lin C-P. Precision medicine for frontotemporal dementia. Front Psychiatry. 2019;21(10):75.
  56. Malcolm T, Lerman A, Korytkowska M, Vonk JMJ, Obler LK (2019) Primary progressive aphasia in bilinguals and multilin- guals. In: Schwieter (ed) The handbook of neuroscience of mul- tilingualism. Wiley, Hoboken, pp 572–591
  57. Mendez MF (2004) Semantic dementia in multilingual patients. J Neuropychiatry Clin Neurosci 16:381. appi.neuropsych.16.3.381
  58. Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Move Disord. 2005;20(6):742–5. 32. Hughes LE, Rittman T, Regenthal R, et al. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain. 2015;138(Pt 7):1961–75.
  59. Meyer AM, Snider SF, Eckmann CB, Friedman RB. Prophylactic Treatments for Anomia in the Logopenic Variant of Primary Progressive Aphasia: Cross-Language Transfer. Aphasiology. 2015;29(9):1062-1081. doi: 10.1080/02687038.2015.1028327. PMID: 26257456; PMCID: PMC4524746.
  60. Moretti R, Torre P, Antonello RM, et al. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer’s disease and other dementias: a 24-month follow-up of 68 patients. Am J Alz- heimers Dis Other Demen. 2003;18(4):205–14.
  61. Moretti R, Torre P, Antonello RM, et al. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. Eur Neurol. 2003;49(1):13–9.
  62. Onyike CU, Shinagawa S, Ellajosyula R. Frontotemporal Dementia: A Cross-Cultural Perspective. Adv Exp Med Biol. 2021;1281:141-150. doi: 10.1007/978-3-030-51140-1_10. PMID: 33433874.
  63. Papatriantafyllou JD, Viskontas IV, Papageorgiou SG, Miller BL, Pavlic D, Bingol A, Yener G. Difficulties in detecting behavioral symptoms of frontotemporal lobar degeneration across cultures. Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):77-81. doi: 10.1097/WAD.0b013e318182d874. PMID: 18695586; PMCID: PMC2778241
  64. Placek, K., Massimo, L., Olm, C., Ternes, K., Firn, K., Van Deerlin, V., Lee, E. B., Trojanowski, J. Q., Lee, V. M., Irwin, D., Grossman, M., & McMillan, C. T. (2016). Cognitive reserve in frontotemporal degeneration: Neuroanatomic and neuropsychological evidence. Neurology, 87(17), 1813–1819.
  65. Premi E, Gazzina S, Bozzali M, Archetti S, Alberici A, Cercignani M, et al. (2013) Cognitive Reserve in Granulin-Related Frontotemporal Dementia: from Preclinical to Clinical Stages. PLoS ONE 8(9): e74762.
  66. Rahman S, Robbins TW, Hodges JR, et al. Methylphenidate (’Ritalin’) can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology. 2006;31(3):651–8.
  67. Sanders AE, Hall CB, Katz MJ, Lipton RB (2012) .Non-native language use and risk of incident dementia in the 454 elderly. J Alzheimers Dis 29, 99-108.
  68. Shimomura T, Mori E (1998) Obstinate imitation behaviour in differentiation of frontotemporal dementia from Alzheimer’s disease. Lancet 352: 623–624.
  69. ​​​​​​​Shinagawa S, Ikeda M, Nestor PJ et al (2009) Characteristics of abnormal eating behaviours in frontotemporal lobar degeneration: a cross-cultural survey. J Neurol Neurosurg Psychiatry 80:1413–1414
  70. Shinagawa S, Tsuno N, Nakayama K. Managing abnormal eating behaviours in frontotemporal lobar degeneration patients with topiramate. Psychogeriatrics. 2013;13(1):58–61.
  71. Shinagawa S, Nakajima S, Plitman E, Graff-Guerrero A, Mimura M, Nakayama K, Miller BL. Non-pharmacological management for patients with frontotemporal dementia: a systematic review. J Alzheimers Dis. 2015;45(1):283-93. doi: 10.3233/JAD-142109. PMID: 25737152.
  72. Vercelletto M, Boutoleau-Bretonnière C, Volteau C, et al. Memantine in behavioral variant frontotemporal dementia: nega- tive results. J Alzheimers Dis. 2011;23(4):749–59.
  73. Zahodne LB, Schofield PW, Farrell MT, Stern Y, Manly JJ. Bilingualism does not alter cognitive decline or dementia risk among Spanish-speaking immigrants. Neuropsychology. 2014 Mar;28(2):238-46. doi: 10.1037/neu0000014. Epub 2013 Nov 4. PMID: 24188113; PMCID: PMC3947427.


  • A/Prof Fiona Kumfor  holds a Masters of Clinical Neuropsychology (Macquarie University) and a PhD in Neuroscience (University of New South Wales). She is currently a National Health Medical Research Council Career Development Fellow (2019-2023), Associate Professor in the School of Psychology, University of Sydney and registered Clinical Neuropsychologist. A/Prof Kumfor has >70 publications, published in high-impact, peer-reviewed journals, which have been cited >2000 times and her h-index is 28. She has received >$3.4M in competitive funding to date. She currently leads a team of 8 researchers and is Director of the Sydney Neuropsychology Clinic which aims to improve assessment and treatment of acquired neurological disorders taking a transdiagnostic approach.

  • Dr. Ratnavalli Ellajosyula is a consultant neurologist and specialist in Cognitive Neurology. She obtained a fellowship in Cognitive Neurology under Prof. John Hodges, one of the world’s leading experts in FTD. She started the first memory clinic in India and currently heads a multidisciplinary cognitive disorders clinic in several centres in India. She has extensive clinical experience of more than two decades in diagnosing and managing patients with FTD. She was the PI on two research projects on ‘genetics of FTD’ and ‘bilingualism and PPA’. She has published several important papers on different aspects of FTD. Her first author paper on ‘Prevalence of FTD’ in Neurology has more than 1000 citations. Her recent paper on language loss in bilingual semantic dementia is the largest series so far reported. She has also authored a paper on neuropsychiatric features. She was a co-author on a collaborative paper in Brain journal on guidelines for differentiating FTD from primary psychiatric disorders. She is now leading the section on ‘clinical presentation’ of a multi-author FTD diversity white paper, a collaborative effort of the FTD and diversity Professional Interest groups (PIA) of the Alzheimer Association. She is a member of the International Neuropsychiatric FTD consortium and is a steering committee member of the cognition professional interest area (PIA) of the Alzheimer’s Association.